2m 2m 2m 2m 2m 2m 2m
CANDEL THERAPEUT (CADL)
NASDAQ
$10.19+$0.03 (+0.25%)
Price as of Oct 02, 2026 4:20 PM EDT- $777.4MMarket Cap
- 87.80%1-Year Change
- BiotechnologyIndustry
CANDEL THERAPEUT (CADL)
$10.19+$0.03 (+0.25%)
CADL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.16 | ||
Change | -$0.28 (-2.68%) | ||
Open | $10.72 | ||
High | $10.72 | ||
Low | $10.16 | ||
Previous Close | $10.44 | ||
Volume | 1,037,610 | ||
30-Day Average Volume | 1,185,820 | ||
1-Week Change | -12.03% | ||
1-Month Change | -20.93% | ||
1-Year Change | 87.80% | ||
3-Year Change | 1,004.35% | ||
5-Year Change | -3.24% | ||
Fundamentals | |||
Shares Outstanding | 76.5M | ||
Total Assets | $208.1M | ||
Market Cap | $777.4M | ||
Enterprise Value | $623.7M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$38.9M | ||
Free Cash Flow | -$17.3M | ||
EBIT | -$37.3M | ||
EBITDA | -$37.2M | ||
Net Working Capital | $191.5M | ||
EPS | -$0.52 | ||
Enterprise Value/EBITDA | -17 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -20 | ||
PEG | 0 | ||
Price/Free Cash Flow | -45 | ||
Price/Operating Cash Flow | -45 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue